Allergan reports net profit of $137.8 million for the 2nd quarter ended June 29, up sharply from $28.2 million in the year-ago period. Operating income increased to $181.7 million from $44.6 million. Product revenues were up by 23.6 percent to $972.8 million, or by 21.2 percent on a currency-neutral basis. ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.